Alector announces pricing of public offering of common stock

South san francisco, calif., jan. 17, 2024 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the pricing of an underwritten public offering of 10,869,566 shares of its common stock for total gross proceeds of $75 million before deducting underwriting discounts and commissions and estimated offering expenses payable by alector. the offering is expected to close on january 19, 2024, subject to satisfaction of customary closing conditions. all of the shares in the offering are being sold by alector.
ALEC Ratings Summary
ALEC Quant Ranking